Substance / Medication

Minocycline

Overview

Active Ingredient
minocycline
RxNorm CUI
6980

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

121 trials linked to this intervention

121
Total Trials
5
Recruiting
68
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and safety of topical minocycline preparations for papulopustular rosacea: a systematic review and meta-analysis.
Alamri Awadh, Alsamadani Abdulrahman H, Alraddadi Rose A et al. · Front Med (Lausanne) · 2025
PMID: 40236457Meta-AnalysisFull text (PMC)
Efficacy of minocycline in substance use disorder: A systematic review of preclinical and clinical studies.
Eshrati Sahar, Nikbakhtzadeh Marjan, Arezoomandan Reza et al. · Pharmacol Biochem Behav · 2025
PMID: 39993507Meta-Analysis
Minocycline as a potential anxiolytic drug: systematic review and meta-analysis of evidence in murine models.
Iglesias Lia P, Soares Nicia, Asth Laila et al. · Behav Pharmacol · 2024
PMID: 38375658Meta-Analysis
In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study.
Zhang Weihe, Dong Lingling, Men Peixuan et al. · Diagn Microbiol Infect Dis · 2024
PMID: 39032320Meta-Analysis
Minocycline in the eradication ofinfection: A systematic review and meta-analysis.
Zhou Kai, Li Cai-Ling, Zhang Hua et al. · World J Gastroenterol · 2024
PMID: 38813048Meta-AnalysisFull text (PMC)
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis.
Panizzutti Bruna, Skvarc David, Lin Sylvia et al. · Int J Mol Sci · 2023
PMID: 36982324Meta-AnalysisFull text (PMC)
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta-analysis of RCTs.
Gao Wenwen, Zhu Mingliang, Yin Yanhui et al. · Helicobacter · 2023
PMID: 37839018Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Minocycline (substance)
SNOMED CT
372653009
UMLS CUI
C0026187
RxNorm CUI
6980

Clinical Data

This intervention maps to 14 entities in the Ltrl knowledge graph.

14
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
121
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.